Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -22.52% is 76% above its 5-year average of -92.74%, near the high end of its 5-year range (-272.36%–8.98%).
15.60% below its 12-month average of -19.48%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -14.57%.
NET PROFIT MARGIN
-22.52%
NET PROFIT MARGIN AVG TTM
-19.48%
NET PROFIT MARGIN AVG 3Y
-14.77%
NET PROFIT MARGIN AVG 5Y
-92.74%
NET PROFIT MARGIN AVG 10Y
-170.67%
NET PROFIT MARGIN AVG 15Y
-106.61%
NET PROFIT MARGIN AVG 20Y
-162.16%
CURRENT VS TTM AVG
-15.60%
CURRENT VS 3Y AVG
-52.44%
CURRENT VS 5Y AVG
+75.72%
CURRENT VS 10Y AVG
+86.80%
CURRENT VS 15Y AVG
+78.88%
CURRENT VS 20Y AVG
+86.11%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 623 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Heron Therapeutics, Inc.
Market Cap
$64.71M
Net Profit Margin
-22.52%
TTM Avg
-19.48%
3Y Avg
-14.77%
5Y Avg
-92.74%
Market Cap
$64.94M
Net Profit Margin
-235.00%
TTM Avg
-200.38%
3Y Avg
-100.19%
5Y Avg
-66.80%
Market Cap
$64.68M
Net Profit Margin
-13.72%
TTM Avg
-20.80%
3Y Avg
-11.88%
5Y Avg
-17.10%
Market Cap
$63.41M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$63.23M
Net Profit Margin
-41.36%
TTM Avg
-52.43%
3Y Avg
-63.29%
5Y Avg
-45.57%
Market Cap
$67.60M
Net Profit Margin
163.32%
TTM Avg
-34.49%
3Y Avg
-63.76%
5Y Avg
-75.19%
Market Cap
$62.16M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$68.49M
Net Profit Margin
-33044.00%
TTM Avg
-18819.13%
3Y Avg
-12177.01%
5Y Avg
-8726.92%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Heron Therapeutics, Inc. (HRTX) | $64.71M | -22.52% | -19.48% | -14.77% | -92.74% |
| Gossamer Bio, Inc. (GOSS)vs › | $64.94M | -235.00% | -200.38% | -100.19% | -66.80% |
| InterCure Ltd. (INCR)vs › | $64.68M | -13.72% | -20.80% | -11.88% | -17.10% |
| Cingulate Inc. (CING)vs › | $66.27M | 0.00% | 0.00% | 0.00% | 0.00% |
| Kalaris Therapeutics Inc (KLRS)vs › | $63.41M | 0.00% | 0.00% | 0.00% | 0.00% |
| Alps Group Inc (ALPS)vs › | $63.23M | -41.36% | -52.43% | -63.29% | -45.57% |
| Fortress Biotech, Inc. (FBIO)vs › | $67.60M | 163.32% | -34.49% | -63.76% | -75.19% |
| PDS Biotechnology Corporation (PDSB)vs › | $62.16M | 0.00% | 0.00% | 0.00% | 0.00% |
| iBio, Inc. (IBIO)vs › | $68.49M | -33044.00% | -18819.13% | -12177.01% | -8726.92% |
| Champions Oncology, Inc. (CSBR)vs › | $69.26M | -1.87% | 3.14% | -4.53% | -2.69% |
Operating Margin
-7.2%
Net Profit Margin
-22.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -14.57% |
| 2026-03-31 | -23.37% |
| 2025-12-31 | -7.28% |
| 2025-09-30 | -45.78% |
| 2025-06-30 | -6.40% |
| 2025-03-31 | 6.77% |
| 2024-12-31 | 8.98% |
| 2024-09-30 | -14.78% |
| 2024-06-30 | -25.64% |
| 2024-03-31 | -9.11% |
| 2023-12-31 | -31.33% |
| 2023-09-30 | -79.56% |
| 2023-06-30 | -132.42% |
| 2023-03-31 | -110.65% |
| 2022-12-31 | -66.17% |
| 2022-09-30 | -157.80% |
| 2022-06-30 | -203.98% |
| 2022-03-31 | -272.36% |
| 2021-12-31 | -264.57% |
| 2021-09-30 | -225.60% |
| 2021-06-30 | -271.87% |
| 2021-03-31 | -262.83% |
| 2020-12-31 | -302.26% |
| 2020-09-30 | -291.65% |
| 2020-06-30 | -243.47% |
| 2020-03-31 | -203.07% |
| 2019-12-31 | -165.09% |
| 2019-09-30 | -78.82% |
| 2019-06-30 | -137.00% |
| 2019-03-31 | -199.39% |
| 2018-12-31 | -171.82% |
| 2018-09-30 | -193.80% |
| 2018-06-30 | -223.82% |
| 2018-03-31 | -451.85% |
| 2017-12-31 | -621.61% |
| 2017-09-30 | -488.40% |
| 2017-06-30 | -502.93% |
| 2017-03-31 | -1385.71% |
| 2016-12-31 | -3750.04% |
| 2016-09-30 | -7338.73% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | -106.69% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | -769.72% |
| 2011-03-31 | -359.24% |
| 2010-12-31 | -891.62% |
| 2010-09-30 | -476.35% |
| 2010-06-30 | -676.04% |
| 2010-03-31 | -205.39% |
| 2009-12-31 | -1568.03% |
| 2009-09-30 | -108.68% |
| 2009-06-30 | -28150.00% |
| 2009-03-31 | -37000.00% |
| 2008-12-31 | -18790.48% |
| 2008-09-30 | -9695.31% |
| 2008-06-30 | -4032.89% |
| 2008-03-31 | -5145.86% |
| 2007-12-31 | -5834.09% |
| 2007-09-30 | -3871.90% |
| 2007-06-30 | -1110.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | -180.26% |
| 2005-09-30 | -130.44% |
| 2005-06-30 | -208.64% |
| 2005-03-31 | -92.35% |
| 2004-12-31 | -152.29% |
| 2004-09-30 | -131.76% |
| 2004-06-30 | -190.34% |
| 2004-03-31 | -220.25% |
| 2003-12-31 | -101.47% |
| 2003-09-30 | -83.44% |
| 2003-06-30 | -175.47% |
| 2003-03-31 | 3.07% |
| 2002-12-31 | -11.43% |
| 2002-09-30 | -78.33% |
